Adverse events related to cyclin dependent kinase 4/6 inhibitors: A real-world study based on the FDA Adverse Event Reporting System
Year: 2026
Type: article
Source: Breast Care
DOI: 10.1159/brc/abrag015
Authors: Shuhuai Wang, Yuting Li, Siqi Zhang
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7236170849
